Concepedia

Yi-Jang Lin

YL

9

Publications

2K

Citations

9

H-Index

2015

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Massachusetts Institute of Technology

Center for Systems Biology

Dana-Farber Cancer Institute

Yi-Jang Lin is an author at Harvard University specializing in medicine, pathology, and immunology.

ORCID

Top concepts

Publications per year

2015–2021

9

Publications

9

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

Christina Pfirschke, Camilla Engblom, Steffen Rickelt et al. · Immunity · 2016 · 914 citations · Full text

, , +5

Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF <sup>high</sup> neutrophils

Camilla Engblom, Christina Pfirschke, Rapolas Žilionis et al. · Science · 2017 · 364 citations · Full text

EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors

Christine M. Fillmore, Chunxiao Xu, Pooja Desai et al. · Nature · 2015 · 252 citations · Full text

, , +11

Tissue-Specific Oncogenic Activity of KRASA146T

Emily J. Poulin, Asim K. Bera, Jia Lu et al. · Cancer Discovery · 2019 · 189 citations · Full text

Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D

Christian W. Johnson, Yi-Jang Lin, Derion Reid et al. · Cell Reports · 2019 · 84 citations · Full text

Rows per page

1–5 of 9